Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
Clinical trial NCT01702623 · COMPLETED
Trial details
- NCT number
- NCT01702623
- Sponsor
- Roxane Laboratories
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2009-09-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.